Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer

被引:67
|
作者
Cho, Hanbyoul [1 ]
Lee, You Sun [1 ]
Kim, Julie [1 ,2 ]
Chung, Joon-Yong [2 ]
Kim, Jae-Hoon [1 ]
机构
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Obstet & Gynecol, Seoul 135720, South Korea
[2] NCI, Appl Mol Pathol Lab, Pathol Lab, NIH, Bethesda, MD 20892 USA
基金
新加坡国家研究基金会;
关键词
GLUT-1; Ovarian cancer; Microarray; Biomarker; Immunohistochemistry; GLUCOSE-TRANSPORTER; EXPRESSION; CARCINOMA; SURVIVAL; ANGIOGENESIS; CELLS;
D O I
10.3109/07357907.2013.849722
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate themicroarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EOC/normal cells ratio of 5.51 based on microarray. Real-time PCR and immunohistochemistry demonstrated that GLUT-1 expression was significantly increased in EOC (p=.029 and p<.001, respectively). On survival analysis, GLUT-1 overexpression (HR= 4.80, p=.027) and lymph nodemetastases (HR= 8.35, p=.016) conferred a significantly worse overall survival. In conclusion, GLUT-1 expression is remarkably upregulated in EOC and predicts a poor overall survival.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 50 条
  • [41] Overexpression of Karyopherin-2 in Epithelial Ovarian Cancer and Correlation With Poor Prognosis
    Zheng, Min
    Tang, Li
    Huang, Long
    Ding, Hui
    Liao, Wen-Ting
    Zeng, Mu-Sheng
    Wang, Hui-Yun
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (04) : 884 - 891
  • [42] Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancer
    Connor, Elizabeth, V
    Saygin, Caner
    Braley, Chad
    Wiechert, Andrew C.
    Karunanithi, Sheelarani
    Crean-Tate, Katie
    Abdul-Karim, Fadi W.
    Michener, Chad M.
    Rose, Peter G.
    Lathia, Justin D.
    Reizes, Ofer
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01)
  • [43] FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
    Wang, Yan
    Sun, Mengjing
    Liu, Jibin
    Liu, Ying
    Jiang, Chunyi
    Zhu, Huijun
    Wang, Wei
    Wang, Yao
    ONCOLOGY LETTERS, 2020, 19 (01) : 795 - 804
  • [44] CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer
    Liu, N.
    Zhang, J.
    Zhang, L. -Y.
    Wang, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (12) : 3713 - 3718
  • [45] Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer
    Wang, Lishuang
    Mao, Yuanfu
    Du, Guiqin
    He, Chunbo
    Han, Shiyu
    TUMOR BIOLOGY, 2015, 36 (04) : 2465 - 2472
  • [46] Expression and clinical significance of glucose transporter-1 in pancreatic cancer
    Lu, Kai
    Yang, Jian
    Li, De-Chun
    He, Song-Bing
    Zhu, Dong-Ming
    Zhang, Li-Feng
    Zhang, Xu
    Chen, Xiao-Chen
    Zhang, Bing
    Zhou, Jian
    ONCOLOGY LETTERS, 2016, 12 (01) : 243 - 249
  • [47] Overexpression of Rab27B is correlated with distant metastasis and poor prognosis in ovarian cancer
    Ren, Ping
    Yang, Xiao-Qing
    Zhai, Xiao-Lu
    Zhang, Yu-Quan
    Huang, Jian-Fei
    ONCOLOGY LETTERS, 2016, 12 (02) : 1539 - 1545
  • [48] Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis
    Tohma, T
    Okazumi, S
    Makino, H
    Cho, A
    Mochizuki, R
    Shuto, K
    Kudo, H
    Matsubara, K
    Gunji, H
    Matsubara, H
    Ochiai, T
    DISEASES OF THE ESOPHAGUS, 2005, 18 (03) : 185 - 189
  • [49] Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer
    Liu, Shaoqiu
    He, Lewei
    Sheng, Chenchen
    Su, Rongjia
    Wu, Xiaomei
    Sun, Yunyan
    Xi, Xiaowei
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [50] Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients
    Sharen, Gaowa
    Peng, Yaojun
    Cheng, Haidong
    Liu, Yang
    Shi, Yonghong
    Zhao, Jian
    ONCOTARGET, 2017, 8 (12) : 19760 - 19767